ICU MEDICAL INC/DE·4

May 13, 4:55 PM ET

LOPEZ GEORGE A 4

4 · ICU MEDICAL INC/DE · Filed May 13, 2022

Insider Transaction Report

Form 4
Period: 2022-05-12
LOPEZ GEORGE A
DirectorChairmanOther
Transactions
  • Purchase

    Common Stock

    2022-05-12$170.79/sh+4,480$765,119260,089 total
  • Purchase

    Common Stock

    2022-05-12$173.07/sh+7,092$1,227,444272,098 total
  • Purchase

    Common Stock

    2022-05-12$174.66/sh+17$2,969281,444 total
  • Purchase

    Common Stock

    2022-05-12$172.24/sh+4,917$846,885265,006 total
  • Purchase

    Common Stock

    2022-05-12$174.17/sh+9,329$1,624,838281,427 total
Holdings
  • Common Stock

    (indirect: By Partnership)
    886,843
Footnotes (5)
  • [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $170.42 to $171.30, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  • [F2]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $171.64 to $172.63, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  • [F3]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $172.64 to $173.61, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  • [F4]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $173.64 to $174.63, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
  • [F5]All shares sold were purchased at the exact price disclosed.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT